Biotronik Se & Co. Kg
Clinical trials sponsored by Biotronik Se & Co. Kg, explained in plain language.
-
Testing Next-Generation heart pacemaker technology
Disease control OngoingThis study is testing the safety and performance of a new pacemaker system (Amvia pacemaker with Solia CSP S lead) for people who need heart rhythm treatment. The research involves 152 participants in Europe, Australia, and New Zealand who will be followed for up to 12 months aft…
Phase: NA • Sponsor: Biotronik SE & Co. KG • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Heart patients go home same day in new hospital program trial
Disease control OngoingThis study is testing whether it is safe and practical for heart failure patients to receive a special pacemaker and be discharged from the hospital on the same day. It compares outcomes for patients in a same-day program against those who stay in the hospital overnight as usual.…
Sponsor: Biotronik SE & Co. KG • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC
-
Massive heart device study tracks 3,000 patients for Real-World clues
Knowledge-focused OngoingThis study is observing 3,030 heart failure patients who already have or are getting a special heart device called CRT. Researchers are tracking their health outcomes over time through remote monitoring to understand how well these devices work in everyday life. The goal is to id…
Sponsor: Biotronik SE & Co. KG • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC